From November 13, 2023 to December 31, 2023, the company has repurchased 359,000 shares, for CNY 7.64 million. With this, the company has completed the repurchase of 359,000 shares, for CNY 7.64 million under the buyback announced on November 14, 2023.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
19.92 CNY | +3.75% | +14.29% | -12.05% |
EPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-12.05% | 950M | |
-14.35% | 77.13B | |
+14.09% | 8.4B | |
-0.70% | 3.22B | |
+14.70% | 1.64B | |
-10.12% | 1.5B | |
-22.60% | 1.3B | |
-4.20% | 1.25B | |
-10.26% | 1.18B | |
+5.06% | 1.1B |
- Stock Market
- Equities
- 603566 Stock
- News Pulike Biological Engineering, Inc.
- Tranche Update on Pulike Biological Engineering, Inc.'s Equity Buyback Plan announced on November 14, 2023.